🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Veggie Softgel(s) Serving Size
60 Servings
Vitamin Product Type
50% Evidence Coverage

Supplement Facts — Evidence Check

VEGADELIGHT
125 mcg (625% DV)
100 mcg
✅ Within RDA (0.8× RDA of 0.12 mg) 📚 273 studies (Tier A: 9, B: 175)
RDA 0.12mg This product: 0.1mg

Other Ingredients

Coconut Tapioca Starch, Modified Glycerin Water, Purified Turmeric Olive Oil

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (100% of products) Structure/Function (84% of products) Nutrient (73% of products)

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Suggested use: Adults take 1 veggie softgel daily with food, or as recommended by a qualified healthcare professional.

This product is intended for individuals who do not obtain the RDI through their daily diet.

⚠️ Warnings & Precautions

Caution: Keep out of reach of children and pets.

Do not consume with other high dose Vitamin D supplements. Do not exceed recommended daily intake. Do not use if safety seal is damaged or missing.

Consult with a qualified healthcare professional prior to using this product especially if you are pregnant, nursing, have a diagnosed medical condition, or are taking a prescription medication (e.g., anticoagulants [coumadin/warfarin[).

Contains: Tree nuts (coconut).

🧪 Formulation Notes

Quality matters Third party tested cGMP compliant

Non GMO Project Verified nongmoproject.org Non-GMO Verified Gluten-free

Certified Vegan Vegan.org

Plant-based Supports bone & immune health

125mcg (5000 IU) D3 100mcg K2 D3 + K2 with coconut MCT

Vegan

Proudly manufactured in the USA with carefully selected ingredients of domestic and international origins. Lot number & best by date printed on bottom of bottle.

Additional Information

Non GMO Project Verified nongmoproject.org Certified Vegan Vegan.org

Store at room temperature, in a dry place. Protect from excessive heat, freezing, humidity and light.

HDPE Non BPA Please recycle Scan for more

@sportsresearch

Product Details

UPC / SKU 0 23249 01134 7
DSLD Entry Date 2024-02-22
Product Type Vitamin
Form Softgel Capsule
DSLD ID 309609
Data Updated 2026-04-11

Research Evidence

332 Research Sources
59 Avg Quality Score
220 Meta Analysis
56 Systematic Review
30 Rct
16 Clinical Trial
3 Guideline
3 Regulatory Source
1 Narrative Review
1 Other
1 Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014
View all evidence for Vitamin K →

Compare Similar Products

View all Vitamin K products →